Table 2.
The Relationship between Serum Concentrations of IGF-1 and IGFBP-3 and BC Risk by Case-Control
| Variables | Cases Mean (SD) | Controls Mean (SD) | P value |
|---|---|---|---|
| Age of participant | 45.4 (10.5) | 41.8 (8.9) | 0.002 |
| Waist Circumference (cm) | 91.1 (7.6) | 88.7 (11.6) | 0.029 |
| BMI | 29.8 (5.6) | 29.0 (5.6) | 0.221 |
| IGF-1 (ng/ml) | 119.5 (59.0) | 92.3 (48.8) | ≤0.001 |
| IGFBP-3 (µg/mL) | 5.8 (22.4) | 3.4 (1.4) | 0.261 |
BC, Breast Cancer; SD,Standard deviation; BMI, Body mass index; IGF-1, Insulin-like Growth Factor-1; IGFBP-3, Insulin-like Growth Factor binding protein-3; P ≤ 0.05, Significant.